GSTP1 and prostate neoplasm: Many researchers pinned great hopes on the development of diagnostic testing based on the analysis of the methylation status of cytosines in the promoter region of the GSTP1 gene, since it was assumed that in genomic DNA obtained from prostate tumor tissue, cytosines in CpG dinucleotides are methylated in almost 100% of cases.